Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ruxrungtham

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
AIDS (London, England)|April 1, 1992
Clinical correlation of the immunological markers of HIV infection in individuals from ThailandS Sirivichayakul, P Phanuphak, M Hanvanich, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Survey of reverse transcriptase from the heterosexual epidemic of human immunodeficiency virus type 1 CRF01_AE in Thailand from 1990 to 2000S Sirivichayakul, W Chantratita, R Sutthent, et al.
Thorax|September 24, 1999
Interferon gamma for diagnosing tuberculous pleural effusionsS Wongtim, U Silachamroon, K Ruxrungtham, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1996
Potent activity of 2'-beta-fluoro-2',3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID miceK Ruxrungtham, E Boone, H Ford, et al.
International Journal of Epidemiology|May 29, 1998
Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, ThailandS G Wannamethee, S Sirivichayakul, A N Phillips, et al.
Journal of Investigational Allergology & Clinical Immunology|February 15, 2011
Production and immunogenicity of hypoallergenic codon-optimized DNA vaccine encoding mature Der p 1 allergenP Pulsawat, S Piboonpocanun, S Sirivichayakul, et al.
HIV Medicine|March 8, 2011
Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected ThaisN Edwards-Jackson, Sj Kerr, Hv Tieu, et al.
HIV Medicine|February 20, 2007
Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatmentP Srasuebkul, C Ungsedhapand, K Ruxrungtham, et al.
HIV Medicine|September 22, 2012
Longitudinal analysis of integrase N155H variants in heavily treated patients failing raltegravir-based regimensH L Nguyen, C Charpentier, N Nguyen, et al.
HIV Medicine|April 6, 2005
The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapyP Cardiello, P Srasuebkul, E Hassink, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|April 1, 1992
Clinical correlation of the immunological markers of HIV infection in individuals from ThailandS Sirivichayakul, P Phanuphak, M Hanvanich, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Survey of reverse transcriptase from the heterosexual epidemic of human immunodeficiency virus type 1 CRF01_AE in Thailand from 1990 to 2000S Sirivichayakul, W Chantratita, R Sutthent, et al.
Thorax|September 24, 1999
Interferon gamma for diagnosing tuberculous pleural effusionsS Wongtim, U Silachamroon, K Ruxrungtham, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1996
Potent activity of 2'-beta-fluoro-2',3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID miceK Ruxrungtham, E Boone, H Ford, et al.
International Journal of Epidemiology|May 29, 1998
Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, ThailandS G Wannamethee, S Sirivichayakul, A N Phillips, et al.
Journal of Investigational Allergology & Clinical Immunology|February 15, 2011
Production and immunogenicity of hypoallergenic codon-optimized DNA vaccine encoding mature Der p 1 allergenP Pulsawat, S Piboonpocanun, S Sirivichayakul, et al.
HIV Medicine|March 8, 2011
Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected ThaisN Edwards-Jackson, Sj Kerr, Hv Tieu, et al.
HIV Medicine|February 20, 2007
Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatmentP Srasuebkul, C Ungsedhapand, K Ruxrungtham, et al.
HIV Medicine|September 22, 2012
Longitudinal analysis of integrase N155H variants in heavily treated patients failing raltegravir-based regimensH L Nguyen, C Charpentier, N Nguyen, et al.
HIV Medicine|April 6, 2005
The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapyP Cardiello, P Srasuebkul, E Hassink, et al.
Pageof 5